PHX 0.00% 5.0¢ pharmx technologies limited

Ann: Preliminary Final Report, page-5

  1. 4,179 Posts.
    lightbulb Created with Sketch. 455
    Revenue was largely stable from H1 ($6,382) to H2 ($6,184), so $198k less in the second half, which looks much better than the year on year comparison.

    The 2nd half reduction in revenue also accounts for most of the reduction in net profit from H1 ($223k) to H2 ($28k), which is $195k less in H2.

    Corum suggests that the cross-selling of their peripheral products has increased in H2, then Corum Clear will be launched in about a month, which should again enhance the cross-selling platform even further.

    If the business can continue to manage its cost base from here, but grow revenue, it should largely hit the bottom line.

    Net assets of $14m, including $5m in cash available for $8m market cap.

    I think Corum should stop looking for acquisitions and find someone to buy the business and Corum Clear for $20m, then Bill can keep the ASX shell and do something else with it.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
(20min delay)
Last
5.0¢
Change
0.000(0.00%)
Mkt cap ! $29.92M
Open High Low Value Volume
5.0¢ 5.0¢ 5.0¢ $109.2K 2.184M

Buyers (Bids)

No. Vol. Price($)
1 40000 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 50034 1
View Market Depth
Last trade - 13.18pm 26/07/2024 (20 minute delay) ?
PHX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.